Study on Human Bioequivalence of Triprerelin Acetate for Injection

NCT06683066 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (CRPC)

Interventions

DRUG: Triprorelin for injection
DRUG: Diphereline

Sponsor

The Affiliated Hospital of Qingdao University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]